CXCR5+CD8 T cells correlate with disease-free or overall survival in pancreatic, colon, follicular lymphoma, gastric, high-grade serous ovarian, hepatocellular, and bladder cancers and thus is considered a potential biomarker (15, 17, 20, 23, 25, 26). Here, CXCR5 is linked to follicular lymphoma.